(Q43653227)

English

Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial (English)

1 reference

Europe PubMed Central

25 November 2017

proliferative vitreoretinopathy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

25 November 2017

author name string

Asaria RH

1

1 reference

Europe PubMed Central

25 November 2017

Kon CH

2

1 reference

Europe PubMed Central

25 November 2017

Charteris DG

4

1 reference

Europe PubMed Central

25 November 2017

Wong D

5

1 reference

Europe PubMed Central

25 November 2017

Khaw PT

6

1 reference

Europe PubMed Central

25 November 2017

Aylward GW

7

1 reference

Europe PubMed Central

25 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

108

1 reference

Europe PubMed Central

25 November 2017

7

1 reference

Europe PubMed Central

25 November 2017

1179-1183

1 reference

Europe PubMed Central

25 November 2017

Changing Concepts of Failures After Retinal Detachment Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The classification of retinal detachment with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucocorticosteroid inhibition of intraocular proliferation after injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Intraocular Proliferations with Intravitreal Corticosteriods

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral colchicine for the treatment of experimental traction retinal detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxol treatment of experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil for the Treatment of Massive Periretinal Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ocular toxicity of fluorouracil after vitrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An overview of potential applications of heparin in vitreoretinal surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An updated classification of retinal detachment with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900589-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(01)00589-9

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43653227&oldid=2102337253"